CSIMarket


Ideaya Biosciences Inc   (IDYA)
Other Ticker:  
 


 

Ideaya Biosciences Inc

IDYA's Financial Statements and Analysis



Ideaya Biosciences Inc reported in III. Quarter net earnings per share of $0.04 an improvement compare to net loss per share of $-0.31 recorded a year ago and an improvement compare to net loss per share of $-0.57 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ 0.04 $  30 Mill
$+0.35     $+21M     +230.87 %



Ideaya Biosciences Inc 's Revenue rose by 230.87 % in III. Quarter (Sep 30 2022) year on year, to $30 million and advanced by 407.59 % sequentially.


Ideaya Biosciences Inc is Expected to report next financial results on March 16, 2023.

More on IDYA's Income Statement



Ideaya Biosciences Inc 's net income of $1.615 million in III. Quarter increased from net loss of $-11.582 million III. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-22.056 million recorded in previous quarter.

More on IDYA's Growth

IDYA's Cash flow In III. Quarter company's net cash flow was $53 million, capital expenditures fell by 140.39%, to $-1 millions compare to same quarter a year ago and rose by -43.28% from II. Quarter (Jun 30 2022).

More on IDYA's Cash flow Statement


Ideaya Biosciences Inc does not pay out common stock dividend.

In trailing twelve-month period Ideaya Biosciences Inc payed $ -1.96 cash per share, on a free-cash flow basis .